These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 396341)

  • 1. The effect of some protease substrates and inhibitors on chemotaxis and protease activity of human polymorphonuclear leukocytes.
    Grady PG; Davis AT; Shapira E
    J Infect Dis; 1979 Dec; 140(6):999-1003. PubMed ID: 396341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neutrophil chemotaxis by protease inhibitors. Differential effect of inhibitors of serine and thiol proteases.
    Barna JB; Kew RR
    Inflammation; 1995 Oct; 19(5):561-74. PubMed ID: 8543371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory action of synthetic proteinase inhibitors and substrates on the chemotaxis of rat polymorphonuclear leukocytes in vitro.
    Nakagawa H; Watanabe K; Sato K
    J Pharmacobiodyn; 1988 Oct; 11(10):674-8. PubMed ID: 3065473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes.
    Kitagawa S; Takaku F; Sakamoto S
    J Clin Invest; 1980 Jan; 65(1):74-81. PubMed ID: 6243143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Eglin C on the function of human neutrophils in vitro.
    Suter S; Chevallier I
    Biol Chem Hoppe Seyler; 1988 Jul; 369(7):573-8. PubMed ID: 2852014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.
    Lazarus GS; Yost FJ; Thomas CA
    Science; 1977 Dec; 198(4322):1162-3. PubMed ID: 929193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esterases of the polymorphonuclear leukocyte capable of hydrolyzing acetyl DL-phenyl-alanine beta-naphthyl ester. Relationship to the activatable esterase of chemotaxis.
    Becker EL; Ward PA
    J Exp Med; 1969 Mar; 129(3):569-84. PubMed ID: 5812915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes.
    Becker EL
    J Exp Med; 1972 Feb; 135(2):376-87. PubMed ID: 4551218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of polymorphonuclear leukocyte capping by a chemotactic factor.
    Mandell BF; Spilberg I; Lichtman J
    J Immunol; 1977 Apr; 118(4):1375-8. PubMed ID: 321690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochemical demonstrations of protease in human peripheral blood cells by use of new alpha-naphthyl ester substrates.
    Honda T; Hitomi Y; Niinobe M; Fujii S
    Histochemistry; 1983; 77(3):299-302. PubMed ID: 6408033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteoglycans, proteases, chemotaxis, and aggregation of inflammatory, cells.
    Lynn WS; Mukherjee C
    Infect Immun; 1979 Jan; 23(1):14-8. PubMed ID: 570554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA paraprotein inhibition of human neutrophil chemotaxis. Reduced activity following treatment with IgA-specific protease from Neisseria gonorrhoeae.
    Van Epps DE; Plaut A; Bernier GM; Williams RC
    Inflammation; 1980 Jun; 4(2):137-44. PubMed ID: 6771212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute-phase proteinase inhibitors on chemotaxis of rat polymorphonuclear leukocytes in vitro.
    Nakagawa H; Sato K; Miyai H; Yamamoto Y
    J Pharmacobiodyn; 1989 Jun; 12(6):363-9. PubMed ID: 2778627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 125I-chemotactic peptide uptake by protease inhibitors.
    Niedel J; Frothingham R; Cuatrecasas P
    Biochem Biophys Res Commun; 1980 May; 94(2):667-73. PubMed ID: 7396927
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition by elastase inhibitors of the formyl Met Leu Phe-induced chemotaxis of rat polymorphonuclear leukocytes.
    Hornebeck W; Soleilhac JM; Tixier JM; Moczar E; Robert L
    Cell Biochem Funct; 1987 Apr; 5(2):113-22. PubMed ID: 3495371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for cell-bound proteases in the mechanism of human neutrophil activation with various stimuli.
    Smith RJ; Speziale SC; Sam LM; Justen JM; Bowman BJ
    Inflammation; 1986 Sep; 10(3):257-70. PubMed ID: 3527962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chymotrypsin-specific protease inhibitors decrease H2O2 formation by activated human polymorphonuclear leukocytes.
    Frenkel K; Chrzan K; Ryan CA; Wiesner R; Troll W
    Carcinogenesis; 1987 Sep; 8(9):1207-12. PubMed ID: 3621459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease.
    Oda T; Kojima Y; Akaike T; Ijiri S; Molla A; Maeda H
    Infect Immun; 1990 May; 58(5):1269-72. PubMed ID: 1691142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.